Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Durantel

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Expert Review of Anti-Infective Therapy|October 16, 2004
Current and emerging therapeutic approaches to hepatitis C infectionDavid Durantel, Vanessa Escuret, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Management and prevention of drug resistance in chronic hepatitis BFabien Zoulim, David Durantel, Paul Deny
Antiviral Research|August 16, 2015
Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic optionsDulce Alfaiate, Paul Dény, David Durantel
Viruses|April 29, 2017
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic ConceptsSuzanne Faure-Dupuy, Julie Lucifora, David Durantel
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2018
Liver macrophages: Friend or foe during hepatitis B infection?Suzanne Faure-Dupuy, David Durantel, Julie Lucifora
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studiesMarie-Jeanne Marion, Olivier Hantz, David Durantel
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Cells|October 17, 2020
Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus InfectionsJulie Lucifora, Maud Michelet, Anna Salvetti, et al.
Viruses|October 14, 2011
Innate antiviral immune responses to hepatitis B virusMalika Ait-Goughoulte, Julie Lucifora, Fabien Zoulim, et al.
Nature Reviews. Drug Discovery|June 1, 2013
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesLars Petter Jordheim, David Durantel, Fabien Zoulim, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Expert Review of Anti-Infective Therapy|October 16, 2004
Current and emerging therapeutic approaches to hepatitis C infectionDavid Durantel, Vanessa Escuret, Fabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
Management and prevention of drug resistance in chronic hepatitis BFabien Zoulim, David Durantel, Paul Deny
Antiviral Research|August 16, 2015
Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic optionsDulce Alfaiate, Paul Dény, David Durantel
Viruses|April 29, 2017
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic ConceptsSuzanne Faure-Dupuy, Julie Lucifora, David Durantel
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2018
Liver macrophages: Friend or foe during hepatitis B infection?Suzanne Faure-Dupuy, David Durantel, Julie Lucifora
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studiesMarie-Jeanne Marion, Olivier Hantz, David Durantel
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Cells|October 17, 2020
Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus InfectionsJulie Lucifora, Maud Michelet, Anna Salvetti, et al.
Viruses|October 14, 2011
Innate antiviral immune responses to hepatitis B virusMalika Ait-Goughoulte, Julie Lucifora, Fabien Zoulim, et al.
Nature Reviews. Drug Discovery|June 1, 2013
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesLars Petter Jordheim, David Durantel, Fabien Zoulim, et al.
Pageof 13